Advocate general gives opinion on data exclusivity


An advocate general (AG) has said that regulatory authorities in “concerned” EU member states handling drug marketing authorisations (MAs) are co-responsible for approved documents on data exclusivity.

Advocate general, data exclusivity, CJEU, Court of Justice of the European Union, Helm, Astellas, medicine, marketing authorisation